Whole-genome sequencing of newborn babies presents ethical quandaries
It can bring medical benefits—but it could also reveal bad news
IMAGINE FOR a moment that your unborn child has a rare genetic disorder. Not something at least vaguely familiar, such as sickle-cell anaemia or cystic fibrosis, but rather a condition buried deep within the medical dictionary. Adrenoleukodys trophy, maybe. Or Ehlers-Danlos syndrome.
This article appeared in the Leaders section of the print edition under the headline “Private letters, public promise”
From the May 14th 2022 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Leaders
Health warnings about alcohol give only half the story
Enjoyment matters as well as risk
Pete Hegseth’s culture war will weaken America’s armed forces
Donald Trump’s nominee for defence risks driving away talent
The capitalist revolution Africa needs
The world’s poorest continent should embrace its least fashionable idea
Just because Indonesia has nickel, doesn’t mean it should make EVs
Economic nationalists are making a reckless bet
Donald the Deporter
Could a man who makes ugly promises of mass expulsion actually fix America’s immigration system?
Mark Zuckerberg’s U-turn on fact-checking is craven—but correct
Social-media platforms should not be in the business of defining truth